Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal subcutaneous naloxone dose for intrathecal opioid‑induced pruritus after elective caesarean section
2007-007815-99Phase 4Unknown
- Sponsor
- Leeds Teaching Hospitals NHS Trust
- Start
- Apr 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of naloxone in drug-induced pruritus and pruritus, sponsored by Leeds Teaching Hospitals NHS Trust. Primary endpoint: Visual analogue scores for pruritus at multiple time points. Status: unknown.
02
Drugs
naloxone
03
Conditions
drug-induced prurituspruritus
Beyond the preview
Go deeper on 2007-007815-99.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007815-99.